lithocholic acid has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HC; Chiang, CH; Hung, WC; Li, WS; More, SV; Wang, CH | 1 |
| Balraj, G; Chang, TT; Chen, JY; Cheng, HC; Huang, SM; Juan, HF; Li, WS; Sun, YC; Tang, YA; Wang, SC; Wang, YC; Wu, KW; Wu, LW | 1 |
2 other study(ies) available for lithocholic acid and Lung Neoplasms
| Article | Year |
|---|---|
A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Female; Glycolipids; Humans; Integrins; Lithocholic Acid; Lung Neoplasms; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Knockout; N-Acetylneuraminic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; RNA Splicing Factors; RNA-Binding Proteins; Sialyltransferases; Signal Transduction; Treatment Outcome | 2010 |
A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways.
Topics: Animals; Cell Line; Cell Line, Tumor; Focal Adhesion Kinase 1; Humans; Integrins; Lithocholic Acid; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neovascularization, Pathologic; Paxillin; Proteomics; Sialyltransferases; Signal Transduction | 2011 |